PI
Cancer Center Amsterdam
-
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
van der Maas, N. G., Versluis, J., Nasserinejad, K., van Rosmalen, J., Pabst, T., Maertens, J., Breems, D., Manz, M., Cloos, J., Ossenkoppele, G. J., Floisand, Y., Gradowska, P., Löwenberg, B., Huls, G., Postmus, D., Pignatti, F. & Cornelissen, J. J., 1 Dec 2024, In: Blood Cancer Journal. 14, 1, 56.Research output: Contribution to journal › Article › Academic › peer-review
-
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
van de Loosdrecht, A. A., Cremers, E. M. P., Alhan, C., Duetz, C., in ’t Hout, F. E. M., Visser-Wisselaar, H. A., Chitu, D. A., Verbrugge, A., Cunha, S. M., Ossenkoppele, G. J., Janssen, J. J. W. M., Klein, S. K., Vellenga, E., Huls, G. A., Muus, P., Langemeijer, S. M. C., de Greef, G. E., te Boekhorst, P. A. W., Raaijmakers, M. H. G., van Marwijk Kooy, M., & 20 others , Apr 2024, In: Leukemia. 38, 4, p. 840-850 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study
Ravandi, F., Subklewe, M., Walter, R. B., Vachhani, P., Ossenkoppele, G., Buecklein, V., Döhner, H., Jongen-Lavrencic, M., Baldus, C. D., Fransecky, L., Pardee, T. S., Kantarjian, H., Yen, P. K., Mukundan, L., Panwar, B., Yago, M. R., Agarwal, S., Khaldoyanidi, S. K. & Stein, A., 2024, (E-pub ahead of print) In: Leukemia and Lymphoma.Research output: Contribution to journal › Article › Academic › peer-review
- All publications